Universal Ibogaine Inc. (IBOGF)
USD 0.02
(1.67%)
USD 0.02
(1.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 5.81 Million CAD | 50.51% |
| 2021 | 3.86 Million CAD | 6423.67% |
| 2020 | 59.24 Thousand CAD | -13.95% |
| 2019 | 68.85 Thousand CAD | -60.93% |
| 2018 | 176.22 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 847.23 Thousand CAD | 6.53% |
| 2023 Q1 | 795.29 Thousand CAD | -33.9% |
| 2023 Q3 | 847.31 Thousand CAD | 0.01% |
| 2022 Q4 | 1.2 Million CAD | -20.54% |
| 2022 FY | 5.81 Million CAD | 50.51% |
| 2022 Q3 | 1.51 Million CAD | 6.09% |
| 2022 Q2 | 1.42 Million CAD | -11.08% |
| 2022 Q1 | 1.6 Million CAD | 7598.29% |
| 2021 Q3 | 11.56 Thousand CAD | -70.19% |
| 2021 FY | 3.86 Million CAD | 6423.67% |
| 2021 Q1 | 19.21 Thousand CAD | 145.13% |
| 2021 Q4 | 20.85 Thousand CAD | 80.27% |
| 2021 Q2 | 38.79 Thousand CAD | 101.93% |
| 2020 Q1 | 13.07 Thousand CAD | -41.86% |
| 2020 Q2 | 13.27 Thousand CAD | 1.54% |
| 2020 Q4 | 7838.00 CAD | -24.66% |
| 2020 FY | 59.24 Thousand CAD | -13.95% |
| 2020 Q3 | 10.4 Thousand CAD | -21.65% |
| 2019 Q3 | 15.62 Thousand CAD | 82.94% |
| 2019 FY | 68.85 Thousand CAD | -60.93% |
| 2019 Q4 | 22.48 Thousand CAD | 43.91% |
| 2019 Q2 | 8542.00 CAD | -41.23% |
| 2019 Q1 | 14.53 Thousand CAD | -51.78% |
| 2018 Q2 | 18.57 Thousand CAD | -89.62% |
| 2018 Q1 | 178.95 Thousand CAD | 85.51% |
| 2018 Q3 | 40.27 Thousand CAD | 116.78% |
| 2018 Q4 | 30.14 Thousand CAD | -25.15% |
| 2018 FY | 176.22 Thousand CAD | 0.0% |
| 2017 Q4 | 96.47 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 10.86 Million USD | 46.471% |
| Skye Bioscience, Inc. | 13.54 Million USD | 57.062% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 84.386% |
| Nascent Biotech, Inc. | 2.22 Million USD | -160.868% |
| Qrons Inc. | 643.67 Thousand USD | -803.722% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | 74.681% |
| CSL Limited | 3.44 Billion USD | 99.831% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 80.317% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -15.371% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -529.885% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 89.873% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -1300.083% |
| Rebus Holdings, Inc. | 664 Thousand USD | -776.062% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -335.593% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -1393.213% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 63.667% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 93.297% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -18.283% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -2122.572% |
| SQZ Biotechnologies Company | 85.61 Million USD | 93.206% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -99.471% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -287.313% |
| Mesoblast Limited | 5.9 Million USD | 1.439% |
| Marizyme, Inc. | 19.23 Million USD | 69.766% |
| Genus plc | 147.7 Million USD | 96.062% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 33.741% |
| Pharming Group N.V. | 225.49 Million USD | 97.42% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -183.938% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -333.608% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 30.243% |
| ContraFect Corporation | 56.88 Million USD | 89.775% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -31.946% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -293.376% |
| IMV Inc. | 37.7 Million USD | 84.574% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -108.47% |
| MultiCell Technologies, Inc. | 567.42 USD | -1025075.179% |
| ONE Bio Corp. | 6.44 Million USD | 9.728% |
| Accustem Sciences Inc. | 3.74 Million USD | -55.27% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 93.232% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -993.508% |
| Q BioMed Inc. | 3.43 Million USD | -69.266% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 76.463% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -121.389% |
| Biomind Labs Inc. | 994.18 Thousand USD | -485.109% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 94.144% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -230.575% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 13.411% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -212.012% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 23368.196% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -216.989% |
| GB Sciences, Inc. | 1.42 Million USD | -309.505% |
| Alpha Cognition Inc. | 9.7 Million USD | 40.065% |
| HST Global, Inc. | 140.9 Thousand USD | -4028.29% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -417.112% |
| Halberd Corporation | 74.84 Thousand USD | -7672.439% |
| Enzolytics Inc. | 2.17 Million USD | -166.897% |
| Agentix Corp. | 1.37 Million USD | -324.059% |
| Resverlogix Corp. | 12.71 Million USD | 54.24% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -59.34% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.621% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -457.189% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -141.88% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -268.318% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -70.839% |
| AVAX Technologies, Inc. | 7.31 Million USD | 20.426% |
| Zenith Capital Corp. | 8.94 Million USD | 34.954% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.295% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -33291.017% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -136.916% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -3291.687% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -202.828% |
| Kadimastem Ltd | 2.41 Million USD | -141.36% |
| Helix BioMedix, Inc. | 1.97 Million USD | -194.977% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -3105.251% |
| LadRx Corporation | 3.81 Million USD | -52.607% |
| Cell Source, Inc. | 4.32 Million USD | -34.487% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -529.885% |
| NovAccess Global Inc. | 2.46 Million USD | -135.817% |
| Affymax, Inc. | 39.38 Million USD | 85.231% |
| Itoco Inc. | 919.14 Thousand USD | -532.877% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -37.246% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -419.844% |
| Mobile Lads Corp. | 554.54 Thousand USD | -948.975% |
| CytoDyn Inc. | 18.05 Million USD | 67.787% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -23011.959% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -2543.176% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -309.711% |
| SYBLEU INC | 160.87 Thousand USD | -3515.859% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -220.266% |
| International Stem Cell Corporation | 5.27 Million USD | -10.359% |
| Bioxytran, Inc. | 3.82 Million USD | -52.273% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -10950.205% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -28494.843% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 83.96% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -259.521% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -690.537% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -86.983% |
| Neutra Corp. | 243.82 Thousand USD | -2285.787% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 66.678% |
| PureTech Health plc | 144.59 Million USD | 95.977% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 71.61% |
| IXICO plc | 4.7 Million USD | -23.583% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 33.875% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 95.06% |
| CSL Limited | 3.89 Billion USD | 99.851% |
| Cellectis S.A. | 97.32 Million USD | 94.023% |